Clinical care and other categories posters: Lipids and fatty liver

Clinical care and other categories posters: Lipids and fatty liver P394 Causes of elevated alanine aminotransferase in Type 2 diabetesCL MORRISON1, TS Purewal2 and PJ Weston21Healthy Prestatyn Iach, Betsi Cadwaladr University Local Health Board, Prestatyn, UK, 2Diabetes Centre, Royal Liverpool Hospital, Liverpool, UKIntroduction: Monitoring liver function tests as part of the diabetes annual review is considered good practice as non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH) can cause few or no symptoms. They are also commonly used to monitor statin therapy, although there is little evidence of systematic hepatotoxity.Method: This study was undertaken in one large primary care centre to examine the causes, prevalence and investigation of deranged liver function tests with elevated levels of alanine aminotransferase (ALT) above 100 IU/l.Results: Of 1,580 with diabetes, 394 (24.9%) had a raised ALT above the reference range, of these 9.4% (37/394) had elevated levels above 100 IU/l, ALT 168.7 IU/l (±64.5,102 to 419) (mean, SD, range) [male 23 (62.2%), age 64.2 years (±13.6, 37 to 94), HbA1c 74.8mmol/mol (±22.9, 41 to 121), body mass index 33kg/m2 (±7.5, 21.8 to 49.8), cholesterol 5.9mmol/l (±1.5, 2.4 to 10.4), triglyceride 3.9mmol/l (±3.9, 0.5 to 21.7), alkaline phosphatase 158.5 IU/l (±104.3, 40 to 561; 45.9% abnormally raised)]. Liver ultrasound identified 13 (35.1%) with NAFLD in whom 9 (69.2%) ALT improved. Six (16.2%) were alcohol dependent, 6 (16.2%) had transient raised ALT due to acute illness, 3 (8.1%) were receiving disease‐modifying anti‐rheumatic drugs and 2 (5.4%) had gastrointestinal malignancy.Conclusion: Abnormal ALT levels are frequently encountered in the diabetes population and existing co‐morbidities or acute illness can contribute to liver dysfunction. NAFLD was caused by poor glycaemic control in the majority of cases but with treatment interventions improved. In the absence of economic studies to support screening for NAFLD, there is no nationally recognised investigation and treatment pathway for abnormal ALTs. This would help improve primary care management and identify those at risk of liver fibrosis or cirrhosis that need onward referral. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetic Medicine Wiley

Clinical care and other categories posters: Lipids and fatty liver

Free
1 page

Loading next page...
1 Page
 
/lp/wiley/clinical-care-and-other-categories-posters-lipids-and-fatty-liver-2v0lm28jJj
Publisher
Wiley
Copyright
Diabetic Medicine © 2018 Diabetes UK
ISSN
0742-3071
eISSN
1464-5491
D.O.I.
10.1111/dme.43_13571
Publisher site
See Article on Publisher Site

Abstract

P394 Causes of elevated alanine aminotransferase in Type 2 diabetesCL MORRISON1, TS Purewal2 and PJ Weston21Healthy Prestatyn Iach, Betsi Cadwaladr University Local Health Board, Prestatyn, UK, 2Diabetes Centre, Royal Liverpool Hospital, Liverpool, UKIntroduction: Monitoring liver function tests as part of the diabetes annual review is considered good practice as non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH) can cause few or no symptoms. They are also commonly used to monitor statin therapy, although there is little evidence of systematic hepatotoxity.Method: This study was undertaken in one large primary care centre to examine the causes, prevalence and investigation of deranged liver function tests with elevated levels of alanine aminotransferase (ALT) above 100 IU/l.Results: Of 1,580 with diabetes, 394 (24.9%) had a raised ALT above the reference range, of these 9.4% (37/394) had elevated levels above 100 IU/l, ALT 168.7 IU/l (±64.5,102 to 419) (mean, SD, range) [male 23 (62.2%), age 64.2 years (±13.6, 37 to 94), HbA1c 74.8mmol/mol (±22.9, 41 to 121), body mass index 33kg/m2 (±7.5, 21.8 to 49.8), cholesterol 5.9mmol/l (±1.5, 2.4 to 10.4), triglyceride 3.9mmol/l (±3.9, 0.5 to 21.7), alkaline phosphatase 158.5 IU/l (±104.3, 40 to 561; 45.9% abnormally raised)]. Liver ultrasound identified 13 (35.1%) with NAFLD in whom 9 (69.2%) ALT improved. Six (16.2%) were alcohol dependent, 6 (16.2%) had transient raised ALT due to acute illness, 3 (8.1%) were receiving disease‐modifying anti‐rheumatic drugs and 2 (5.4%) had gastrointestinal malignancy.Conclusion: Abnormal ALT levels are frequently encountered in the diabetes population and existing co‐morbidities or acute illness can contribute to liver dysfunction. NAFLD was caused by poor glycaemic control in the majority of cases but with treatment interventions improved. In the absence of economic studies to support screening for NAFLD, there is no nationally recognised investigation and treatment pathway for abnormal ALTs. This would help improve primary care management and identify those at risk of liver fibrosis or cirrhosis that need onward referral.

Journal

Diabetic MedicineWiley

Published: Jan 1, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off